MedTrace Logo

Headache Inducing Effect of Cromakalim in Migraine Patients

NCT03228355 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-06-19

No results posted yet for this study

Summary

To investigate the role of KATP channels on the cerebral hemodynamic in migraine patients.

Conditions

  • Headache, Migraine

Interventions

DRUG

Levcromakalim

To investigate the role of Levcromakalim on cerebral hemodynamic in migraine patients

DRUG

Saline

To investigate the role of levcromakalim compared with saline cerebral hemodynamic in migraine patients.

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Messoud Ashina, Professor · DHC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-24
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03228355 on ClinicalTrials.gov